Latest News- Biologics Contract Development And Manufacturing Organization (CDMO) Market: Mammalian is expected to lead the Type segment during 2025-2029

The Biologics Contract Development And Manufacturing Organization (CDMO) Market is being driven by Availability of cost-efficient resources in emerging markets

The Biologics Contract Development And Manufacturing Organization (CDMO) Market is expected to grow at a CAGR of 13.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 16324.6 million. In the pharmaceutical sector, technological advancements have revolutionized drug development, encompassing not only research and development but also the analytical tools employed. Given the intricacy and time-consuming nature of drug development, the increasing adoption of data analytics for clinical data synthesis is expediting the process. A prime example is the implementation of big data in healthcare, including pharmaceuticals, to facilitate informed decisions regarding research and development. Data analytics plays a pivotal role in identifying prospective drug candidates, creating simulation models to forecast drug efficacy, determining target patient populations through diverse sources, and monitoring and mitigating potential side effects at early stages. 

Get more information on Biologics Contract Development And Manufacturing Organization (CDMO) Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Mammalian
  • Microbial
• Product Type
  • Biologics
  • Biosimilars
• Service
  • CMO
  • CRO
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Availability of cost-efficient resources in emerging markets
• Strong research and development pipeline of biologics therapeutics
• Growing need to focus on core competencies

However, the market also witnesses some limitations, which are as follows:

• Capacity utilization and constraints
• Stringent policies related to entry of new biologics
• Serialization issues faced by CDMOs due to multiple production lines

Benefits of Buying Global Biologics Contract Development And Manufacturing Organization (CDMO) Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Biologics Contract Development And Manufacturing Organization (CDMO) Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Biologics Contract Development and Manufacturing Organization (CDMO) market encompasses various services including microbial fermentation, cell culture, and protein expression. CDMOs utilize advanced purification technologies, bioreactor design, and optimization techniques for upstream and downstream processes. They ensure process validation, stability studies, and analytical method development for regulatory filings and clinical trial management. CDMOs prioritize supply chain security, quality assurance, and quality control while optimizing costs through process control, monitoring, and in-process controls. They cater to emerging biosimilar approval pathways, regulations, interchangeability, gene editing technologies, and advanced therapies such as car-t therapy and mRNA vaccines. The landscape of biologics is marked by intense competition, patent landscape, intellectual property considerations, and innovation in bioprocessing, with future advancements in emerging technologies shaping the industry.

Market Research Overview

The Biologics Contract Development and Manufacturing Organization (CDMO) market is a significant segment within the larger global pharmaceuticals industry. This market encompasses organizations specializing in biologics development, including drug substance manufacturing, drug product manufacturing, clinical trial materials, and commercial manufacturing, as well as fill finish services. The global pharmaceuticals market, which includes manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is projected to experience growth due to several key factors. One such factor is the increasing global population aging, with the proportion of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe projected to reach a similar ratio by 2030. This demographic shift will drive demand for new and innovative pharmaceutical solutions, including biologics, which are often used to treat age-related conditions.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/